MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Burden of Eye disease in Parkinson’s disease (PD)

    N. Butt, M. Khwaja, A. Chatterjee (Reading, United Kingdom)

    Objective: To review the burden of eye pathologies in patients with Parkinson’s disease. Background: Parkinson’s disease and eye problems are common in older patients. Alterations…
  • 2018 International Congress

    Study of prevalence of non-motor symptoms in typical and atypical parkinsonism as compared to age and sex matched healthy controls

    N. Barad, C. Sankhla (Mumbai, India)

    Objective: 1) To study prevalence and clinical characteristics of non-motor symptoms (NMS) in idiopathic parkinson disease (IPD) and atypical Parkinsonism (APD) as compared to age…
  • 2018 International Congress

    Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson’s disease?

    A. Sarwar, S. Moore (Houston, TX, USA)

    Objective: To determine if REM sleep behavior disorder (RBD) is associated with excessive daytime sleepiness (ES) in military veterans with Parkinson’s disease (PD). Background: Nearly…
  • 2018 International Congress

    Multimorbidity predicts quality of life but not motor severity in early Parkinson’s disease

    R. Gravell, G. Duncan, T. Khoo, D. Burn, A. Sayer, R. Barker, R. Lawson, A. Yarnall (Newcastle upon Tyne, United Kingdom)

    Objective: To explore the associations between multimorbidity, severity of motor symptoms, and quality of life (QoL) in people with early PD. Background: Multimorbidity is defined…
  • 2018 International Congress

    Gastrointestinal Symptoms and Enteric Nerve Dysfunction in A53T Mice

    R. McQuade, P. Rajasekhar, S. Diwakarla, R. Constable, D. Poole, J. Berger, D. Finkelstein, J. Furness (Melbourne, Australia)

    Objective: To investigate the relationship between α synucleinopathy-induced enteric neuropathy and gastrointestinal dysfunction in A53T mice. Background: Approximately 80-90% of PD patients suffer from GI…
  • 2018 International Congress

    Degeneration of vagus nerve but not of accessory and phrenic nerve in Parkinson’s disease revealed by high-resolution ultrasound

    U. Walter, P. Tsiberidou, M. Kersten, A. Storch, M. Löhle (Rostock, Germany)

    Objective: To test the hypothesis that the vagus nerve is measurably atrophic in idiopathic Parkinson’s disease (PD). Background: The vagus nerve is discussed to represent…
  • 2018 International Congress

    Restless legs syndrome in Parkinson’s disease patients: a comparative study on prevalence, clinical features, motor and non-motor symptoms

    S.Y. You, J.S. Lee, S.M. Jeon, Y.W. Cho (Daegu, Republic of Korea)

    Objective: We investigate the prevalence of restless legs syndrome in Parkinson’s disease patients and to identify associated clinical features, motor and non-motor symptoms. Background: Restless…
  • 2018 International Congress

    Comorbid REM sleep behavior disorder and impulse control disorder symptoms in early parkinson’s disease: The PPMI cohort

    M.L. Fantini, F. Durif, JC. Corvol, D. Weintraub, C. Caspell-Garcia (Clermont Ferrand, France)

    Objective: To assess the prevalence of Impulse Control Disorder symptoms (ICD) in Parkinson's disease with probable REM sleep behavior disorder (i.e. RBD assessed by questionnaire,…
  • 2018 International Congress

    Risk estimation in the years preceding diagnosis of Parkinson’s disease in the PREDICT-PD cohort

    S. Auger, D. Rack, J. Bestwick, G. Giovannoni, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To test and refine the use of probability-based algorithms to identify individuals at high-risk of developing Parkinson’s disease (PD). Background: Neurodegeneration preceding a formal…
  • 2018 International Congress

    Pharmacological modulation of lysosomal glucocerebrosidase activity in the Thy1-aSYN mouse model of Parkinson’s disease

    K. Belarbi, E. Cuvelier, H. Carrie, M.A. Bonte, W. Sibran, C. Leghay, J. Von Gerichten, V. Nordström, R. Sandhoff, T. Comptdaer, N. Jouy, E. Mutez, A. Destee, C. Pincon, B. Gressier, M.C. Chartier-Harlin (Lille, France)

    Objective: To study the pharmacological modulation of glucocerebrosidase activity in the Thy1-aSYN mouse model of Parkinson's disease (PD). Background: PD is a complex neurodegenerative disorder…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley